Using human stem cell models researchers at indiana university school of medicine found they could.
Glaucoma stem cell 2020.
Patients have elevated intraocular pressure and progressive visual field loss.
Indianapolis more than 3 million americans have glaucoma a serious eye condition causing vision loss.
Using human stem cell models researchers at indiana university school of medicine found they could analyze deficits within cells damaged by glaucoma with the potential to use this information to develop new strategies to slow the disease process.
Glaucoma physician september 2020 issue.
Glaucoma is a neurodegenerative disease as a leading cause of global blindness.
There is a great deal of hope and enthusiasm for the role of stem cells in the future treatment of glaucoma that is firmly supported by groundbreaking strong.
Patients with glaucoma should only consider receiving stem cell treatment in the context of a well regulated clinical trial after consultation with their personal ophthalmologist.
It is an exciting time for the adult stem cell field as the pace of new discoveries and understanding about how stem cells can be used for potential therapies is moving quickly.
Retinal ganglion cell rgc apoptosis and optic nerve damage are the main pathological changes.
Using human stem cell models researchers at indiana university school of medicine found they could analyze deficits within cells damaged by glaucoma with the potential to use this information to develop new strategies to slow the disease process.
However there are currently no fda approved stem cell treatments for glaucoma.
More than 3 million americans have glaucoma a serious eye condition causing vision loss.